Cargando…
Stem cell transplantation for type 1 diabetes mellitus
BACKGROUND: The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide β cell regeneration. CONCLUSION: High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce co...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758595/ https://www.ncbi.nlm.nih.gov/pubmed/19825196 http://dx.doi.org/10.1186/1758-5996-1-4 |
_version_ | 1782172603268464640 |
---|---|
author | Voltarelli, Júlio C Couri, Carlos Eduardo Barra |
author_facet | Voltarelli, Júlio C Couri, Carlos Eduardo Barra |
author_sort | Voltarelli, Júlio C |
collection | PubMed |
description | BACKGROUND: The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide β cell regeneration. CONCLUSION: High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus. |
format | Text |
id | pubmed-2758595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27585952009-10-08 Stem cell transplantation for type 1 diabetes mellitus Voltarelli, Júlio C Couri, Carlos Eduardo Barra Diabetol Metab Syndr Review BACKGROUND: The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide β cell regeneration. CONCLUSION: High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus. BioMed Central 2009-09-16 /pmc/articles/PMC2758595/ /pubmed/19825196 http://dx.doi.org/10.1186/1758-5996-1-4 Text en Copyright © 2009 Voltarelli and Couri; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Voltarelli, Júlio C Couri, Carlos Eduardo Barra Stem cell transplantation for type 1 diabetes mellitus |
title | Stem cell transplantation for type 1 diabetes mellitus |
title_full | Stem cell transplantation for type 1 diabetes mellitus |
title_fullStr | Stem cell transplantation for type 1 diabetes mellitus |
title_full_unstemmed | Stem cell transplantation for type 1 diabetes mellitus |
title_short | Stem cell transplantation for type 1 diabetes mellitus |
title_sort | stem cell transplantation for type 1 diabetes mellitus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758595/ https://www.ncbi.nlm.nih.gov/pubmed/19825196 http://dx.doi.org/10.1186/1758-5996-1-4 |
work_keys_str_mv | AT voltarellijulioc stemcelltransplantationfortype1diabetesmellitus AT couricarloseduardobarra stemcelltransplantationfortype1diabetesmellitus |